Search Results - D. Modi

Patient‐reported outcome thresholds and their associations with survival, adverse events, and quality of life in a pooled analysis of breast cancer trials by Bradley D. Menz, Natansh D. Modi, Ahmad Y. Abuhelwa, Nicole M. Kuderer, Gary H. Lyman, Sandra M. Swain, Ganessan Kichenadasse, Adel Shahnam, Mark Haseloff, Agnes Vitry, Elke Rammant, Imogen Ramsey, Raymond J. Chan, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

Get full text

Associations of Commonly Used Concomitant Medications With Survival and Adverse Event Outcomes in Breast Cancer by Natansh D. Modi, Ahmad Y. Abuhelwa, Nicole M. Kuderer, Lee X. Li, Gary H. Lyman, Bogda Koczwara, Ganessan Kichenadasse, Luke A. Selth, Ceara Rickard, Mark Haseloff, Agnes Vitry, Richard Woodman, Jessica M. Logan, Huah Shin Ng, Michael D. Wiese, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

Get full text

130 | TISLELIZUMAB, AN ANTI‐PD‐1 ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: FINAL ANALYSIS FROM THE LYSA PHASE 2 TIRHOL STUDY BGB‐A317‐210 by H. Ghesquières, K. Bouabdallah, M. André, P. Quittet, C. Borel, A. Stamatoullas Bastard, M. Gilbertson, F. Le Bras, C. Thieblemont, B. Delapierre, M. Touati, P. Feugier, L. Renaud, N. Morineau, T. Gastinne, I. Chaillol, R. Ramchandren, H. Shah, D. Modi, H. Allewelt, P. Fustier, J. Xu, R. Delarue, F. Morschhauser, C. Rossi

Get full text